Update
$Ocugen(OCGN.US$ Reuters· just
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
